KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Sales (2016 - 2025)

Historic Return on Sales for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to 0.04%.

  • Evolent Health's Return on Sales fell 100.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.0% for FY2022, which is 100.0% up from last year.
  • As of Q3 2025, Evolent Health's Return on Sales stood at 0.04%, which was down 100.0% from 0.04% recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Return on Sales ranged from a high of 0.01% in Q1 2021 and a low of 0.13% during Q1 2025
  • For the 5-year period, Evolent Health's Return on Sales averaged around 0.02%, with its median value being 0.01% (2023).
  • In the last 5 years, Evolent Health's Return on Sales soared by 300bps in 2022 and then tumbled by -1100bps in 2025.
  • Quarter analysis of 5 years shows Evolent Health's Return on Sales stood at 0.04% in 2021, then soared by 99bps to 0.0% in 2022, then tumbled by -2869bps to 0.01% in 2023, then tumbled by -247bps to 0.04% in 2024, then dropped by -23bps to 0.04% in 2025.
  • Its Return on Sales stands at 0.04% for Q3 2025, versus 0.04% for Q2 2025 and 0.13% for Q1 2025.